Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25363631 | 0.86 | POLB (0.54) | HDAC8MEN1KMT2AALDH1A1NPC1 | |
| SCHEMBL7472706 | 0.86 | HDAC8 (0.48) | L3MBTL1HDAC8 | |
| SCHEMBL6439701 | 0.86 | PPARA (0.54) | L3MBTL1HDAC8HTTPPARA | |
| SCHEMBL25362868 | 0.86 | SMN1; SMN2 (0.49) | HDAC8 | |
| SCHEMBL16673260 | 0.85 | L3MBTL1 (0.52) | L3MBTL1HPGDPPARAMEN1KMT2A | |
| SCHEMBL18720317 | 0.84 | PLA2G4B (0.57) | L3MBTL1HTTALDH1A1POLB | |
| SCHEMBL3170185 | 0.84 | HDAC8 (0.43) | L3MBTL1HDAC8ALDH1A1POLB | |
| SCHEMBL25364367 | 0.83 | HDAC8 (0.44) | L3MBTL1HDAC8POLB | |
| SCHEMBL25364810 | 0.83 | L3MBTL1 (0.53) | L3MBTL1CYP1A2MEN1KMT2AALDH1A1 | |
| SCHEMBL25364212 | 0.82 | HDAC8 (0.43) | L3MBTL1HDAC8POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4216946-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-116437913-A | Pharmaceutical compounds for treating complement-mediated disorders | 艾其林医药公司 | 2023-07-14 | — | — | CN | disclosed |
| WO-2022066774-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2022-03-31 | — | — | WO | disclosed |